Canada Life’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Sell |
11,620
-12,162
| -51% | -$322K | ﹤0.01% | 1671 |
|
|
2025
Q1 | $575K | Sell |
23,782
-59,797
| -72% | -$1.45M | ﹤0.01% | 1578 |
|
|
2024
Q4 | $3.36M | Sell |
83,579
-696
| -0.8% | -$28K | 0.01% | 1030 |
|
|
2024
Q3 | $5.34M | Buy |
84,275
+1,859
| +2% | +$118K | 0.01% | 829 |
|
|
2024
Q2 | $4.36M | Buy |
82,416
+5,780
| +8% | +$306K | 0.01% | 895 |
|
|
2024
Q1 | $6.3M | Buy |
76,636
+67,877
| +775% | +$5.58M | 0.01% | 708 |
|
|
2023
Q4 | $162K | Hold |
8,759
| – | – | ﹤0.01% | 1870 |
|
|
2023
Q3 | $97K | Buy |
8,759
+4,233
| +94% | +$46.9K | ﹤0.01% | 1968 |
|
|
2023
Q2 | $74K | Buy |
4,526
+775
| +21% | +$12.7K | ﹤0.01% | 1959 |
|
|
2023
Q1 | $63K | Buy |
+3,751
| New | +$63K | ﹤0.01% | 2035 |
|
|
2022
Q2 | – | Sell |
-3,830
| Closed | -$12K | – | 2465 |
|
|
2022
Q1 | $12K | Hold |
3,830
| – | – | ﹤0.01% | 2419 |
|
|
2021
Q4 | $18K | Hold |
3,830
| – | – | ﹤0.01% | 2398 |
|
|
2021
Q3 | $24K | Hold |
3,830
| – | – | ﹤0.01% | 2396 |
|
|
2021
Q2 | $23K | Hold |
3,830
| – | – | ﹤0.01% | 2461 |
|
|
2021
Q1 | $24K | Hold |
3,830
| – | – | ﹤0.01% | 2482 |
|
|
2020
Q4 | $22K | Hold |
3,830
| – | – | ﹤0.01% | 2523 |
|
|
2020
Q3 | $22K | Hold |
3,830
| – | – | ﹤0.01% | 2423 |
|
|
2020
Q2 | $27K | Hold |
3,830
| – | – | ﹤0.01% | 2430 |
|
|
2020
Q1 | $18K | Hold |
3,830
| – | – | ﹤0.01% | 2394 |
|
|
2019
Q4 | $30K | Buy |
+3,830
| New | +$30K | ﹤0.01% | 2412 |
|
|
2019
Q3 | – | Sell |
-7,219
| Closed | -$60K | – | 2247 |
|
|
2019
Q2 | $60K | Hold |
7,219
| – | – | ﹤0.01% | 2393 |
|
|
2019
Q1 | $71K | Hold |
7,219
| – | – | ﹤0.01% | 2172 |
|
|
2018
Q4 | $53K | Buy |
+7,219
| New | +$53K | ﹤0.01% | 2350 |
|